A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

Summary

The purpose of this study is to determine whether Mycobacterium w in combination with Paclitaxel plus Cisplatin are effective in Advanced Non Small Cell Lung cancer.

Conditions

• Non Small Cell Lung Cancer

Interventions

DRUG

Paclitaxel & Cisplatin

Chemotherapeutic agent

BIOLOGICAL

Mycobacterium w.

Immunomodulator

Sponsors & Collaborators

• Cadila Pharnmaceuticals

  lead INDUSTRY

Principal Investigators

• R K Chaudhary, MD · Acharya Tulsi Regional Cancer Treatment & Research Institute

• Rajeev Gupta, MD · Patel Hospital Pvt. Ltd.

• Anup Majumdar, MD · Institute of Post Graduate Medical Education & Research

• A. Rajkumar, MD · V.N. Cancer Center GKNM Hospital

• Rajeev Seam, MD · Regional Cancer center, Indira Gandhi Medical College

• A.K. Patel, MD · Choithram Hospital and Research Centre

• Chanchal Goswami, MD · B.P.Poddar Hospital and Medical Research Ltd.

• Jaydip Biswas, MD · Chittaranjan National Cancer Institute

• Ritwik Pandyea, MD · Netaji Subhash Chandra Bose Cancer Research Institute

• Aloke G Dastidar, MD · Bankura Sammilani Medical College

• Narayanankutty Warrier, MD · Malabar Institute of Medical Science (MIMS)

• Ashutosh N Aggarwal, MD · Post Graduate Institute of Medical Education and Research, Chandigarh

• Apurva Patel, MD · Gujarat Cancer & Research Institute

• Santanu Chaudhary, MD · R.S.T. Cancer Hospital & Research Centre

• Rajeev Prasad, MD · Regional Cancer Centre, Indira Ghandhi Institute of Medical Science

• Ramakrishna Malladi, MD · MNJ Institute of Oncology, Regional Cancer Centre

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2008-06-30

Primary Completion

2010-12-31

Completion

2010-12-31

Countries

• India

Study Locations